|
|
|
DCI
sets up expert group to look into DRL Grastim claims |
| |
The Drugs Controller General
of India has directed Dr Reddy’s Laboratories to desist from
using the word “Filgrastim” in the package inserts and other
literature of its anti-cancer drug, Grastim, till an expert
group looks into the issue of whether Grastim is identical to
Filgrastim. |
|
|
Zydus
Cadila lines up novel drug delivery system for launch |
| |
In the already overcrowded
Rs 250 crore Quinolone market, the Ahmedabad-based Rs 1,000
crore Zydus Cadila Group is all set to launch its latest offering
‘Oflin’ on Monday. |
|
|
Cipla
offers anthrax drug supply to US |
| |
Cipla has offered to supply
large quantities of an anti-anthrax drug to the United States
as further cases of exposure to the bacteria emerged there.
|
|
|
GMR
Vasavi to implement Vemagiri power project |
| |
GMR Vasavi Power Corporation
of the Bangalore-based GMR Group has taken over the implementation
of the 542 mw, Vemagiri power project. This is the second time
that the project is changing hands. |
|
